In addition, Lys‐des‐Arg9‐BK can effectively repair the epithelial mucosal barrier damage caused by colitis, maintain intestinal homeostasis, and reduce the incidence of colitis‐related colon cancer and APC‐deficient adenoma carcinoma by binding to B1R. Here, BDKRB1 is linked to colonic neoplasm.